Latest filing published 14 Aug 2026 for Caris Life Sciences, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
David Paul Fredrickson appears in our data through filings on Caris Life Sciences, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 26 February 2026 and the latest from 14 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 14 August 2026: a share grant, in Caris Life Sciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations